Here we evaluated the identity of MYB breakpoint sites in fusion transcripts from patient-derived xenografts and patient tumors of ACC harboring the t(6;9) translocation, based on which MYB-NFIB expressing system was established for in vitro and in vivo xenograft study model. The gene discussed is MYB; the disease is adrenal cortex carcinoma.